Medication Treatment for Skin Picking Disorder
Selective serotonin reuptake inhibitors (SSRIs) are the first-line pharmacological treatment for skin picking disorder, particularly when cognitive-behavioral therapy is insufficient or when moderate to severe functional impairment exists. 1
First-Line Pharmacological Approach
SSRIs should be considered as second-line treatment (after CBT) for patients aged 12-18 years with moderate to severe functional impairment who haven't responded to behavioral interventions. 1 The evidence base is strongest for fluoxetine, which demonstrated significant superiority over placebo in reducing skin-picking symptoms in controlled trials. 2 In open-label studies followed by double-blind continuation, fluoxetine responders maintained clinically significant improvement when continued on active medication, while those switched to placebo returned to baseline symptom levels. 3
Practical SSRI Implementation:
- Start with fluoxetine at standard dosing, titrating up to 55-80 mg/day as tolerated 2
- SSRIs are particularly indicated when comorbid anxiety or depression is present 1
- The therapeutic effect on skin picking appears independent of changes in depression, anxiety, or obsessive-compulsive symptoms 2
Second-Line Glutamatergic Agents
N-acetylcysteine (NAC) is a well-established alternative with minimal side effects, typically dosed at 1200-2400 mg/day in divided doses. 1 This glutamatergic agent represents an important option when SSRIs are not tolerated or insufficient. 4
Memantine should be considered as second-line pharmacological treatment when CBT is insufficient, unavailable, or not tolerated. 5 Start memantine at 5 mg daily and titrate to 10-20 mg/day over 2-4 weeks to minimize side effects. 5 Memantine can be used as monotherapy or combined with CBT for enhanced outcomes. 5
Third-Line Options for Refractory Cases
Antiepileptic Agents:
Lamotrigine showed promising results in open-label trials, with 66.7% of subjects rated as "much improved" or "very much improved." 6 Mean time to response was 8 weeks at a dose of 200 mg/day, with dosing ranging from 25 mg every other day to 300 mg/day. 6 However, lamotrigine lacks robust controlled evidence and should be reserved for severe, treatment-resistant cases. 1
Topiramate has been mentioned in case reports for severe cases but lacks robust evidence. 1
Other Agents:
- Antipsychotics (olanzapine, aripiprazole) are often combined with antidepressants in treatment-resistant cases 4
- Naltrexone (opioid antagonist) has been studied but requires additional research to establish definitive efficacy 4
- Mirtazapine has limited evidence but may be considered in specific cases 4
Critical Clinical Considerations
Differential Diagnosis:
It is essential to differentiate skin picking disorder from skin picking in body dysmorphic disorder (BDD), as the underlying motivations differ fundamentally. 5 In BDD, picking is driven by attempts to improve appearance of perceived defects, whereas in excoriation disorder, picking is not primarily motivated by appearance concerns. 1
Medication-Induced Picking:
Consider whether stimulants are contributing to or exacerbating skin picking, and if so, dose reduction or medication holiday may be warranted. 1 Stimulants can cause compulsive behaviors, including skin picking, in some patients. 1
Risk Assessment:
Regular monitoring should assess risk of self-harm, infection, scarring, and tissue damage, as approximately half of young people with body-focused repetitive behaviors report self-harm. 5 Skin picking can lead to significant complications including infection, scarring, and tissue damage. 1
Combination Therapy Strategy
Although habit-reversal psychotherapy has traditionally been first-line treatment, SSRIs are now increasingly being used in combination with psychotherapy when a patient presents with skin picking disorder. 4 Family involvement is recommended, particularly for younger patients, to provide support and reinforce behavioral strategies. 1, 5
Treatment Algorithm Summary:
- Start with CBT with habit reversal training 1
- Add SSRI (fluoxetine preferred) if inadequate response or moderate-severe impairment 1, 2
- Consider N-acetylcysteine (1200-2400 mg/day) or memantine (10-20 mg/day) as alternatives or augmentation 1, 5
- Reserve lamotrigine, antipsychotics, or naltrexone for treatment-resistant cases 4, 6